STK11 and breast carcinoma: Because T47D cells express high endogenous levels of the PRLR LF, but do not exhibit increases in LKB1 mRNA or protein following treatment with PRL, we evaluated the responsiveness of the LKB1 promoter to PRL in this breast cancer cell line.